ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1294

Time to Pregnancy in Women with Systemic Lupus Erythematosus

Meriem El bakali1, Sasha Bernatsky2, Christian A. Pineau3 and Evelyne Vinet4, 1Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3McGill University Health Centre, Montreal, QC, Canada, 4Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Lupus, pregnancy and women's health, Reproductive Health, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Women diagnosed with systemic lupus erythematosus (SLE) during the reproductive period have fewer children than unaffected women. Multiple disease-related factors might influence family size in SLE women, including impaired fertility. However, until now, no one has assessed if women with SLE have a prolonged time to pregnancy (TTP). Therefore, we aimed to measure TTP in women with SLE of reproductive age and compare the occurrence of delayed TTP (i.e. ≥12 months) to general population figures.

Methods:  Female subjects with SLE from the Montreal General Hospital Lupus Clinic, aged 18-45 years, were enrolled between 2012 and 2017. SLE diagnosis was defined in accordance with the American College of Rheumatology classification criteria for SLE. At baseline and annual follow-up visits, the investigators administered a detailed reproductive questionnaire, wherein the TTP was measured. The TTP was assessed retrospectively for all pregnancies occurring prior to the baseline visit and prospectively for all pregnancies occurring over the follow-up period. Disease damage index [i.e. SLICC damage index (SDI) score] and the mean disease activity (i.e. SLEDAI score) over a maximum of 5 years were recorded, as well as previous cyclophosphamide (i.e. ever/never) and other relevant drug exposures. Descriptive statistics were calculated.

Results: A total of 333 women with SLE completed the questionnaire. Among these women, 135 never had a pregnancy and 198 conceived at least once. In women having ≥1 pregnancies, we identified 400 pregnancies for which the TTP was assessed. The TTP was measured retrospectively in 347 pregnancies, of which 226 and 121 respectively occurred prior and after SLE diagnosis. We observed a TTP ≥12 months in 4.9% (95% CI 2.6, 8.8) of pregnancies occurring prior to diagnosis and in 9.1% (95% CI 4.9, 16.0) of pregnancies after diagnosis.

43 pregnancies occurred over the study period and 11.6% (95% CI 4.4, 25.9) had a TTP ≥12 months. None of the women with prolonged TTP had prior cyclophosphamide exposure nor were exposed to steroids while attempting to conceive. However, they tended to be slightly older (median 33 vs 31 years) and more likely to have a SDI ≥1 [60% (95% CI 17, 92) vs 28% (95% CI 14, 47)] compared to women with TTP < 12 months.

Conclusion: Our findings suggest that the occurrence of delayed TTP after SLE diagnosis is similar to that of the general population, which has been consistently reported at approximately 10%. However, larger observational studies, including notably an unexposed group of women without SLE, are needed to confirm our results.


Disclosure: M. El bakali, None; S. Bernatsky, None; C. A. Pineau, None; E. Vinet, None.

To cite this abstract in AMA style:

El bakali M, Bernatsky S, Pineau CA, Vinet E. Time to Pregnancy in Women with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/time-to-pregnancy-in-women-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/time-to-pregnancy-in-women-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology